Jansen-de Vries syndrome: Expansion of the PPM1D clinical and phenotypic spectrum in 34 families.
Jansen-de Vries syndrome
PPM1D
cyclic vomiting
developmental delay
hypersocial personality
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
13
04
2023
received:
20
01
2023
accepted:
20
04
2023
pmc-release:
01
07
2024
medline:
8
6
2023
pubmed:
15
5
2023
entrez:
15
5
2023
Statut:
ppublish
Résumé
Jansen-de Vries syndrome (JdVS) is a neurodevelopmental condition attributed to pathogenic variants in Exons 5 and 6 of PPM1D. As the full phenotypic spectrum and natural history remain to be defined, we describe a large cohort of children and adults with JdVS. This is a retrospective cohort study of 37 individuals from 34 families with disease-causing variants in PPM1D leading to JdVS. Clinical data were provided by treating physicians and/or families. Of the 37 individuals, 27 were male and 10 female, with median age 8.75 years (range 8 months to 62 years). Four families document autosomal dominant transmission, and 32/34 probands were diagnosed via exome sequencing. The facial gestalt, including a broad forehead and broad mouth with a thin and tented upper lip, was most recognizable between 18 and 48 months of age. Common manifestations included global developmental delay (35/36, 97%), hypotonia (25/34, 74%), short stature (14/33, 42%), constipation (22/31, 71%), and cyclic vomiting (6/35, 17%). Distinctive personality traits include a hypersocial affect (21/31, 68%) and moderate-to-severe anxiety (18/28, 64%). In conclusion, JdVS is a clinically recognizable neurodevelopmental syndrome with a characteristic personality and distinctive facial features. The association of pathogenic variants in PPM1D with cyclic vomiting bears not only medical attention but also further pathogenic and mechanistic evaluation.
Identifiants
pubmed: 37183572
doi: 10.1002/ajmg.a.63226
pmc: PMC10330231
mid: NIHMS1897407
doi:
Substances chimiques
PPM1D protein, human
EC 3.1.3.16
Protein Phosphatase 2C
EC 3.1.3.16
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1900-1910Subventions
Organisme : NICHD NIH HHS
ID : K23 HD102589
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS119666
Pays : United States
Organisme : NICHD NIH HHS
ID : P30 HD071593
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH131740
Pays : United States
Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Pediatr Endocrinol Diabetes Metab. 2022;28(1):64-74
pubmed: 35307998
Nat Genet. 2019 Jan;51(1):106-116
pubmed: 30559488
Genet Med. 2019 Aug;21(8):1719-1725
pubmed: 30568311
Mol Genet Genomic Med. 2020 Mar;8(3):e1120
pubmed: 31916397
Blood. 2017 Aug 10;130(6):742-752
pubmed: 28483762
Am J Hematol. 2021 Jun 1;96(6):E207-E210
pubmed: 33725366
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Hum Mutat. 2017 May;38(5):517-523
pubmed: 28229513
Am J Hum Genet. 2017 Apr 6;100(4):650-658
pubmed: 28343630
Nat Commun. 2022 Feb 1;13(1):604
pubmed: 35105861
Am J Med Genet A. 2021 Oct;185(10):3028-3041
pubmed: 34355505
Nat Neurosci. 2016 Sep;19(9):1194-6
pubmed: 27479843
Neurologia (Engl Ed). 2021 May;36(4):330-332
pubmed: 32919790
Eur J Med Genet. 2019 Jan;62(1):70-72
pubmed: 29758292
Brain Dev. 2019 Jun;41(6):538-541
pubmed: 30795918
Sci Rep. 2022 Jun 30;12(1):11106
pubmed: 35773312
J Clin Lab Anal. 2020 Nov;34(11):e23480
pubmed: 32779812
J Hum Genet. 2019 Jun;64(6):545-550
pubmed: 30850729
Genet Med. 2021 Nov;23(11):2029-2037
pubmed: 34211152
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
J Formos Med Assoc. 2022 Apr;121(4):856-860
pubmed: 35016835
J Child Psychol Psychiatry. 2008 Jun;49(6):576-608
pubmed: 18489677
Am J Hum Genet. 2018 Aug 2;103(2):171-187
pubmed: 30032986
iScience. 2022 Aug 09;25(9):104892
pubmed: 36060052